This site uses modern web standards that aren't supported by your browser. For best results, please upgrade to Google Chrome, Microsoft Edge, or Mozilla Firefox.

Webinar: FDA Annual Reporting Period for Drug Products

|

In this webinar, you’ll get an overview of the FDA’s requirements for submissions during the annual reporting period to the electronic Drug Registration and Listing (eDRL) system. That includes drug product site Establishment Registrations and a brand new submission type, the Blanket No Change Certification for drug product listings

WATCH NOW FOR:

  • High Level eRDL Requirements and History Overview
  • FDA Final Rule on eDRL (2016)
  • NEW No Change Certification Requirements for Drug Products (affects most drug product labelers and CMOs)
  • Establishment Registration Requirements Review
  • Consequences of Non-Compliance
  • Q&A from the Audience

Please complete the form to view the webinar recording:



By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close